| |
| |
|
| Insider
Information: |
Sigal Elliot |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
148,221 |
|
|
Indirect Shares
|
78,638 |
|
|
| Direct
Value |
$6,188,227 |
|
|
|
Indirect Value
|
$5,549,704 |
|
|
| Total
Shares |
226,859 |
|
|
| Total
Value |
$11,737,931 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP, CSO & President R... |
2013-06-03 |
148,221 |
2013-06-03 |
47,079 |
Premium* |
|
|
Mead Johnson Nutrition Co |
MJN |
Director |
2017-06-15 |
0 |
2017-06-15 |
0 |
Premium* |
|
|
Spark Therapeutics, Inc. |
ONCE |
Director |
2019-12-17 |
0 |
2015-02-04 |
31,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2012-11-27 |
4 |
GA |
$0.00 |
$0 |
I/I |
200,630 |
100,315 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2013-02-08 |
4 |
S |
$36.79 |
$8,266,897 |
D/D |
(224,705) |
89,429 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2011-05-16 |
4 |
D |
$28.90 |
$6,609,201 |
D/D |
(228,681) |
171,352 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2012-09-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(250,788) |
298,840 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2011-05-16 |
4 |
OE |
$28.90 |
$7,502,803 |
D/D |
259,600 |
470,838 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2013-02-08 |
4 |
OE |
$17.51 |
$5,536,826 |
D/D |
266,082 |
314,134 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2013-04-30 |
4 |
OE |
$24.74 |
$7,641,575 |
D/D |
305,905 |
459,398 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2013-04-30 |
4 |
S |
$39.61 |
$14,004,254 |
D/D |
(353,509) |
105,889 |
0 |
- |
|
133 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
